XML 25 R10.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Line of Credit Assumed $ 176,784,000 $ 0 $ 0
Repayments of Lines of Credit (176,784,000) 0 0
Net Cash Provided by (Used in) Financing Activities (57,074,000) (142,178,000) (145,810,000)
Repayment of Notes Receivable from Related Parties 409,000 409,000 409,000
Cash flows from operating activities:      
Net (loss) (18,281,000) 141,722,000 130,499,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation 22,639,000 23,170,000 21,076,000
Depreciation and amortization 17,360,000 21,337,000 22,482,000
Loss on disposal of fixed assets 561,000 920,000 1,220,000
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 44,273,000 4,050,000 0
Impairment of Leasehold 36,895,000 1,883,000 0
Impairment charges 14,712,000 0  
Deferred taxes (8,353,000) 5,144,000 (2,512,000)
Accrued interest on note receivable – related party (31,000) (40,000) (47,000)
Increase (Decrease) in Accrued Interest Receivable, Net 31,000 40,000 47,000
Repayment of Notes Receivable from Related Parties 409,000 409,000 409,000
Deferred rent expense 0 0 (247,000)
Loss (gain) on sale of marketable securities 0 5,000 189,000
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (8,917,000) (3,000,000) 0
Net benefit in connection with reversal of contingent liability partially offset by acceleration of amortization related to Kate Spade license termination 0 (1,868,000) 0
Provision for Doubtful Accounts 0 8,687,000 12,123,000
Changes in:      
Accounts receivable 13,122,000 (17,837,000) 4,966,000
Due from factor (36,200,000) 24,924,000 (39,959,000)
Inventories 35,476,000 8,436,000 (26,923,000)
Prepaid expenses, prepaid taxes, deposits and other (10,129,000) 9,466,000 14,633,000
Accounts payable and accrued expenses (34,207,000) 11,036,000 21,249,000
Accrued incentive compensation (7,061,000) (249,000) 828,000
Other liabilities (3,350,000) (7,415,000) (5,610,000)
Net cash provided by operating activities 44,206,000 233,780,000 154,376,000
Cash flows from investing activities:      
Purchases of property and equipment (6,562,000) (18,311,000) (12,450,000)
Purchases of marketable securities (73,792,000) (67,935,000) (77,262,000)
Maturity/sale of marketable securities 75,470,000 95,671,000 100,777,000
Acquisitions 0 37,173,000 0
Net cash used in investing activities (4,884,000) (27,748,000) 11,065,000
Cash flows from financing activities:      
Proceeds from exercise of stock options 1,609,000 6,212,000 13,036,000
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 359,000 3,248,000 2,577,000
Payments to Noncontrolling Interests 0 (1,444,000) 1,183,000
business combinations contingent liability payment 0 0 (7,000,000)
Common stock purchased for treasury (46,583,000) (101,768,000) (105,924,000)
Payments of Dividends (12,459,000) (48,426,000) (47,316,000)
Net cash provided by financing activities (57,074,000) (142,178,000) (145,810,000)
Effect of Exchange Rate on Cash and Cash Equivalents 1,515,000 216,000 (814,000)
Net decrease in cash and cash equivalents (16,237,000) 64,070,000 18,817,000
Cash and cash equivalents – beginning of period 264,101,000 200,031,000 181,214,000
Cash and cash equivalents – end of period 247,864,000 264,101,000 200,031,000
Cash paid during the year for:      
Interest 354,000 25,000 36,000
Income taxes $ 5,147,000 $ 29,552,000 $ 37,105,000